Severity of COVID19 infection among patients with multiple sclerosis treated with interferon-beta

---

Copy For Citation

Simpson-Yap S., Pirmani A., De Brouwer E., Peeters L. M., Geys L., Parciak T., ...More

MULTIPLE SCLEROSIS AND RELATED DISORDERS, vol.66, 2022 (SCI-Expanded)

• Publication Type: Article / Letter
• Volume: 66
• Publication Date: 2022
• Doi Number: 10.1016/j.msard.2022.104072
• Journal Name: MULTIPLE SCLEROSIS AND RELATED DISORDERS
• Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, EMBASE, MEDLINE
• Hacettepe University Affiliated: Yes

Abstract

Background: Interferon-beta, a disease-modifying therapy (DMT) for MS, may be associated with less severe COVID-19 in people with MS.